Pipasha N. Biswas
Drug Safety Research Unit
Southampton
England
Name/email consistency: high
- The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. Biswas, P.N., Wilton, L.V., Shakir, S.A. J. Psychopharmacol. (Oxford) (2003)
- The safety of valsartan: results of a postmarketing surveillance study on 12881 patients in England. Biswas, P.N., Wilton, L.V., Shakir, S.W. J. Hum. Hypertens (2002)
- Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting. Biswas, P., Wilton, L.V., Shakir, S.A. Drug. Saf (2001)
- The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Biswasl, P.N., Wilton, L.V., Pearcel, G.L., Freemantle, S., Shakir, S.A. J. Psychopharmacol. (Oxford) (2001)
- Montelukast and improvement of eczema: observations from a prescription event monitoring study in England. Biswas, P., Wilton, L.V., Shakir, S.A. Int. J. Clin. Pharmacol. Ther (2001)